CytomX Therapeutics, Inc.
CytomX Therapeutics, Inc. (CTMX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CTMX · as of Jun 8, 2026
Key Statistics
Explore CytomX Therapeutics, Inc. Data
ctmx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 21 · Buy rate: 81.0%
The CTMX analyst consensus is Buy, based on ratings from 21 Wall Street analysts over the past 3 months. The average 12-month price target is $10.71, representing +264.29% upside from the current price of $2.94.
Competitors & Peers
ctmx competitorsCTMX
ATXS
AVBP
AVXL
DNA
ERASStock Performance
Full HistoryAbout CytomX Therapeutics, Inc.
CytomX Therapeutics, Inc. is a United States-based biopharmaceutical company primarily focused on creating treatments for cancer. The company utilizes its proprietary Probody technology platform to en…
what is cytomx therapeutics, inc. · ctmx stock overview · cytomx therapeutics, inc. company profile · who is cytomx therapeutics, inc. ceo · ctmx NASDAQ · cytomx therapeutics, inc. headquarters · cytomx therapeutics, inc. business segments
About Stock Overview & Key Data
CytomX Therapeutics, Inc. (CTMX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 8, 2015. As of the latest trading session, CTMX stock price is $2.94, with a market capitalization of $472.8M. The stock has returned +13.64% over the past 12 months and -29.58% year-to-date.
According to 21 Wall Street analysts, the consensus rating for CytomX Therapeutics, Inc. stock is Buy, with an average 12-month price target of $10.71. In fiscal year 2025, CytomX Therapeutics, Inc. reported revenue of $76.2M and net income of -$17.4M. For detailed data — including CytomX Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, CytomX Therapeutics, Inc. (CTMX) stock price is $2.94. The stock is traded on NASDAQ under the ticker symbol CTMX. The 52-week range is $1.72 – $8.21.